One of Indonesia's largest pharmaceutical player PT Kalbe Farma Tbk (KLBF) is estimated to book Rp4.73 trillion of revenue and Rp518.32 billion of net profit in the first half this year (1H 2010) compared to the same period last year.
Kalbe Farma's Director Vidjongtius, as reported by Bisnis Indonesia today. said 1H 2010's revenue is estimated a 12% higher than the same period last year of Rp4.22 trillion.
Kalbe's net profit in 1H 2010 is calculated to grow 30% compared to a year earlier of Rp398.71 billion. In 2009, the company pisted Rp9.09 trillion of revenue and Rp929 billion of net profit.
KLBF) has agreed to dispose its subsidiary PT Kageo Igar Jaya Tbk to Kingsford Holdings. In a public statement today, Kalbe Farma will sell 58.10% stakes or 610.06 million shares in Kageo Igar Jaya to Kingsford at Rp185 per share or Rp112.86 billion.
Disclosure: No position at the stock mentioned above.
Print This Article